Vertex Ventures HC
Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Vertex Ventures HC Information
Geographic Data
Address: 76 South Park Street
City: San Francisco
State: CA
Zip: 94107
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
7,514,980Website Global Rank
515Website Monthly Traffic
Twitter Followers
Description
Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health. Their portfolio includes companies at all stages of development, from early-stage companies testing transformative technologies to commercial-stage companies seeking additional growth. With a focus on areas with significant unmet need, Vertex seeks to build great companies that improve the health and quality of human life. They take an active role in our portfolio companies and work with exceptional entrepreneurs, industry partners and fellow venture investors to create value. Their global investment professionals bring deep scientific, medical and business knowledge to every investment they make.
Contact Phone:
+16507298810
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2018 | Twentyeight-Seven Therapeutics | Series A | 65M |
| 12/2017 | Obsidian Therapeutics | Series A | 0 |
| 7/2013 | SENSIMED | Series C | 8.4M |
| 4/2014 | Nuvaira | Series D | 42M |
| 9/2015 | Kona Medical | Debt Financing | 10M |
| 7/2020 | Elevation Oncology | Series A | 32.5M |
| 12/2022 | SonoThera | Series A | 0 |
| 3/2017 | Moximed | Series C | 50M |
| 9/2014 | Ivantis | Series B | 25M |
| 10/2017 | Visterra | Series C | 0 |
| 11/2020 | Elevation Oncology | Series B | 65M |
| 2/2019 | Nuvaira | Equity | 79M |
| 10/2022 | Matchpoint Therapeutics | Series A | 70M |
| 10/2018 | Earlens | Series D | 0 |
| 7/2016 | Innoventure | Series A | - |
| 9/2020 | Palleon Pharmaceuticals | Series B | 100M |
| 12/2019 | Epirium Bio | Series A | 0 |
| 6/2017 | Bicycle Therapeutics | Series B | 52M |
| 7/2021 | NeuSpera Medical | Series C | 65M |
| 6/2017 | Earlens | Series C | 0 |
| 10/2014 | Visterra | Series B | 30M |
| 9/2021 | Allay Therapeutics | Series C | 60M |
| 10/2017 | Palleon Pharmaceuticals | Series A | 47.6M |
| 6/2016 | Visterra | Series C | 23.1M |
| 5/2019 | Twentyeight-Seven Therapeutics | Series A | 15M |
| 6/2016 | Earlens | Series C | 0 |
| 8/2021 | Sonoma BioTherapeutics | Series B | 0 |
| 4/2015 | Twelve | Series C | 35M |
| 9/2021 | Obsidian Therapeutics | Series B | 0 |
| 5/2015 | Moximed | Series B | 33M |
| 6/2019 | BlackThorn Therapeutics | Series B | 76M |
| 4/2021 | Boundless Bio | Series B | 105M |
| 5/2023 | Boundless Bio | Series C | 0 |
| 9/2021 | Allay Therapeutics | Series C | 0 |
| 9/2021 | Obsidian Therapeutics | Series B | 0 |
| 8/2021 | Sonoma BioTherapeutics | Series B | 0 |
| 7/2021 | NeuSpera Medical | Series C | 0 |
| 4/2021 | Boundless Bio | Series B | 0 |
| 11/2020 | Elevation Oncology | Series B | 0 |
| 9/2020 | Palleon Pharmaceuticals | Series B | 0 |
| 7/2020 | Elevation Oncology | Series A | 0 |
| 12/2019 | Epirium Bio | Series A | 0 |
| 6/2019 | BlackThorn Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
